Sen. John Thune (R-SD) (Graeme Sloan/Sipa USA)(Sipa via AP Images)
February 2, 2024 03:41 PM EST
Pharma
FDA+
Law

Draft 340B re­forms in­clude user fees, clar­i­ty around con­tract phar­ma­cies

Nicole DeFeudis

Editor

Six bi­par­ti­san sen­a­tors sug­gest­ed sev­er­al changes to im­prove the “sta­bil­i­ty and trans­paren­cy” of the 340B drug dis­count pro­gram in a long-await­ed draft bill re­leased Fri­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Up­dat­ed: Roche buys out CAR-T part­ner Po­sei­da for $1B up­front

A service from the Financial Times